A detailed history of 626 Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, 626 Financial, LLC holds 4,704 shares of ABBV stock, worth $861,208. This represents 0.53% of its overall portfolio holdings.

Number of Shares
4,704
Previous 4,704 -0.0%
Holding current value
$861,208
Previous $806,000 15.14%
% of portfolio
0.53%
Previous 0.47%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $31,644 - $36,055
-198 Reduced 4.04%
4,704 $856,000
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $55,452 - $62,452
-403 Reduced 7.6%
4,902 $759,000
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $65,459 - $81,460
-494 Reduced 8.52%
5,305 $714,000
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $9,766 - $12,117
-74 Reduced 1.26%
5,799 $940,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $7,949 - $10,058
74 Added 1.28%
5,873 $795,000
Q1 2021

Apr 14, 2022

BUY
$102.3 - $112.62 $593,237 - $653,083
5,799 New
5,799 $940,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track 626 Financial, LLC Portfolio

Follow 626 Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 626 Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 626 Financial, LLC with notifications on news.